Zurcher Kantonalbank Zurich Cantonalbank lessened its stake in athenahealth, Inc. (NASDAQ:ATHN) by 5.7% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 68,768 shares of the health services provider’s stock after selling 4,150 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank owned approximately 0.17% of athenahealth worth $8,552,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also modified their holdings of ATHN. FMR LLC boosted its stake in athenahealth by 0.8% during the second quarter. FMR LLC now owns 5,975,119 shares of the health services provider’s stock valued at $839,803,000 after buying an additional 47,341 shares during the period. Janus Henderson Group PLC bought a new stake in athenahealth during the second quarter worth about $713,856,000. Vanguard Group Inc. increased its holdings in athenahealth by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 3,100,643 shares of the health services provider’s stock valued at $435,795,000 after purchasing an additional 53,361 shares during the period. Capital Research Global Investors increased its holdings in athenahealth by 15.5% during the 2nd quarter. Capital Research Global Investors now owns 2,041,714 shares of the health services provider’s stock valued at $286,963,000 after purchasing an additional 273,660 shares during the period. Finally, BlackRock Inc. grew its holdings in shares of athenahealth by 2.0% during the 2nd quarter. BlackRock Inc. now owns 1,631,993 shares of the health services provider’s stock worth $229,377,000 after acquiring an additional 32,146 shares during the period.
A number of analysts have recently commented on the company. BidaskClub raised athenahealth from a “strong sell” rating to a “sell” rating in a research report on Saturday. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $120.00 price target on shares of athenahealth in a report on Friday, October 27th. SunTrust Banks reaffirmed a “buy” rating and set a $156.00 target price on shares of athenahealth in a research report on Wednesday, October 25th. Leerink Swann reduced their target price on shares of athenahealth from $155.00 to $125.00 and set a “market perform” rating on the stock in a research report on Monday, October 23rd. Finally, Wells Fargo & Company cut their price objective on shares of athenahealth from $190.00 to $155.00 and set an “outperform” rating on the stock in a report on Monday, October 23rd. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and eleven have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $143.22.
athenahealth, Inc. (ATHN) opened at $134.51 on Tuesday. The firm has a market cap of $5,308.75, a PE ratio of 112.42, a price-to-earnings-growth ratio of 4.98 and a beta of 1.57. athenahealth, Inc. has a twelve month low of $90.11 and a twelve month high of $158.66. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.35.
athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.06. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The business had revenue of $304.60 million during the quarter, compared to the consensus estimate of $310.52 million. During the same period in the previous year, the firm posted $0.60 earnings per share. The company’s quarterly revenue was up 10.1% compared to the same quarter last year. equities research analysts anticipate that athenahealth, Inc. will post 1.2 earnings per share for the current fiscal year.
In related news, SVP Bradford Kyle Armbrester sold 1,000 shares of the company’s stock in a transaction dated Friday, October 27th. The shares were sold at an average price of $128.56, for a total value of $128,560.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Jonathan D. Porter sold 300 shares of the company’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $130.38, for a total transaction of $39,114.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 9,283 shares of company stock worth $1,175,908. 3.20% of the stock is currently owned by corporate insiders.
COPYRIGHT VIOLATION NOTICE: This piece of content was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/12/05/zurcher-kantonalbank-zurich-cantonalbank-decreases-position-in-athenahealth-inc-athn.html.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.